COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,304 Articles (22,772 medRxiv, 8,532 bioRxiv)

Most recent first Previous |  Page 1029: Articles 10281-10290  | Next

Increased Risk of Poor Clinical Outcome in COVID-19 Patients with Diabetes Mellitus and in-hospital Mortality Predictors: A Retrospective Cohort from a Tertiary Hospital in Indonesia
Mokoagow, M. I., Saksono Harbuwono, D., Kshanti, I. A., Rumende, C. M., Subekti, I., Harimurti, K., Lie, K. C., Shatri, H.
10.1101/2021.12.30.21266217 — Posted: 2022-01-01
Endothelin-1 is Increased in the Plasma of Patients Hospitalized with Covid-19
Abraham, G., Kuc, R., Althage, M., Greasley, P., Ambery, P., Maguire, J., Wilkinson, I., Hoole, S., Cheriyan, J., Davenport, A.
10.1101/2021.12.30.21268236 — Posted: 2022-01-01
Cross reactivity of spike glycoprotein induced antibody against delta and omicron variants before and after third SARS-CoV-2 vaccine dose
Faustini, S. E., Shields, A. M., Banham, G., Wall, N., Al-Taei, S., Tanner, C., Ahmed, Z., Efstathiou, E., Townsend, N., Price, R., Curry, G., Robertson, L., Nesbit, A., Black, A., MOORE, J., McLaughlin, J., Farnan, J., COVID-HD Birmingham Study Group, , PITCH consortium, , Cunningham, A. F., Harper, L., Moore, T., Drayson, M. T., Richter, A. G.
10.1101/2021.12.30.21268308 — Posted: 2022-01-01
EARLY LENZILUMAB TREATMENT OF COVID-19 PATIENTS USING C-REACTIVE PROTEIN AS A BIOMARKER IMPROVES EFFICACY: RESULTS FROM THE PHASE 3 LIVE-AIR TRIAL
Temesgen, Z., Kelley, C. F., Cerasoli, F., Kilcoyne, A., Chappell, D., Durrant, C., Ahmed, O., Chappell, G., Catterson, V., Polk, C., Badley, A. D., Marconi, V., the LIVE-AIR Study Group
10.1101/2021.12.30.21267140 — Posted: 2022-01-01
Viral cultures, PCR Cycle threshold values and viral load estimation for COVID-19 infectious potential assessment in transplant patients: systematic review - Protocol Version 29 December 2021
Jefferson, T., Spencer, E. A., Maltoni, S., Brassey, J., ONAKPOYA, I., Rosca, E. C., Pludderman, A., Evans, D., Conly, J., Heneghan, C.
10.1101/2021.12.30.21268509 — Posted: 2022-01-01
Point-of-care lung ultrasound predicts severe disease and death due to COVID-19: a prospective cohort study.
Blair, P. W., Siddharthan, T., Liu, G., Bai, J., East, J., Herrera, P., Anova, L., Mahadevan, V., Hossen, S., Seo, S., Sonuga, O., Lawrence, J., Peters, J., Cox, A., Manabe, Y. C., Fenstermacher, K., Shea, S., Rothman, R. E., Hansoti, B., Sauer, L., Crainiceanu, C., Clark, D. V.
10.1101/2021.12.30.21268558 — Posted: 2022-01-01
COVIDFast: A high-throughput and RNA extraction-free method for SARS-CoV-2 detection in swab (SwabFAST) or saliva (SalivaFAST)
Qiu, Y., Lu, L., Halven, A., Terrio, R., Yuldelson, S., Dougal, N., Galbo, F., Lu, A., Gao, D., Blomquist, B., Zevallos, J., Harry, B., Yao, X., Lu, S.-L.
10.1101/2021.12.29.21268527 — Posted: 2022-01-01
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancies and COVID-19: a longitudinal cohort and propensity score analysis
Hueso, t., Godron, A.-S., Lanoy, E., Pakanowski, J., Levi, L. I., Gras, E., Surgers, L., Guemriche, A., Meynard, J.-M., Pirenne, F., Idri, S., Tiberghien, P., Morel, P., Besson, C., Dulery, R., Lamure, S., Hermine, O., Gagneux-Brunon, A., Freymond, N., Grabar, S., Lacombe, K.
10.1101/2021.12.29.21268525 — Posted: 2022-01-01
Estimating the direct Disability-Adjusted Life Years (DALYs) associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: The first full year
Moran, D. P., Montero Pires, S., Wyper, G. M., Devleesschauwer, B., Cuschieri, S., Kabir, Z.
10.1101/2021.12.29.21268120 — Posted: 2022-01-01
Transition of antibody titers after the SARS-CoV-2 mRNA vaccine in Japanese healthcare workers
Kitabatake, M., Ouji-Sageshima, N., Sonobe, S., Furukawa, R., Konda, M., Hara, A., Aoki, H., Suzuki, Y., Imakita, N., Nakano, A., Fujita, Y., Shichino, S., Nakano, R., Ueha, S., Kasahara, K., Muro, S., Yano, H., Matsushima, K., Ito, T.
10.1101/2021.12.28.21268435 — Posted: 2021-12-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).